Literature DB >> 9150365

Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.

G L'Allemain1, J N Lavoie, N Rivard, V Baldin, J Pouyssegur.   

Abstract

We previously described in the CCL39 hamster fibroblast cell line the inhibition of DNA synthesis reinitiation by agents that elevate cyclic AMP. Here, we show that 8Br-cAMP strongly blocks both the growth factor-induced increase in cyclin D1 protein expression and decrease in p27(KIP1) protein levels, leaving untouched the levels of cyclin D3, cdk2 and cdk4. To assess the role of cyclin D1 in the cAMP-mediated inhibition of DNA synthesis, we overexpressed the cyclin D1 gene in CCL39 and analysed the cAMP response in stable transfectants. We showed that the kinase activities associated to G1 cyclin-cdk complexes are significantly more resistant to cAMP in cyclin D1 transfectants than in their normal counterparts, although the serum-induced p27(KIP1) disparition is still cAMP sensitive in cyclin D1 overexpressors. Interestingly, the mitogen-induced DNA synthesis reinitiation is also much less inhibited by cAMP in cyclin D1 transfectants than in control cells. These data clearly establish that the cAMP-inducible blockade of the G1 phase of the cell cycle can be partially alleviated by overexpression of cyclin D1 in hamster fibroblasts, thus strongly suggesting that cyclin D1 protein is one of the major targets for cAMP inhibitory action in fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150365     DOI: 10.1038/sj.onc.1201038

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Growth-inhibitory effect of cyclic GMP- and cyclic AMP-dependent vasodilators on rat vascular smooth muscle cells: effect on cell cycle and cyclin expression.

Authors:  N Kronemann; W A Nockher; R Busse; V B Schini-Kerth
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

2.  {Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells.

Authors:  L Toll; L Jimenez; N Waleh; K Jozwiak; A Y-H Woo; R-P Xiao; M Bernier; I W Wainer
Journal:  J Pharmacol Exp Ther       Date:  2010-11-11       Impact factor: 4.030

3.  Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.

Authors:  Ana Sofia Rocha; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Paula Soares; Pierre P Roger
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

4.  Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.

Authors:  R Cospedal; M Lobo; I Zachary
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

5.  Pharmacologic agents elevating cAMP prevent arginase II expression and proliferation of pulmonary artery smooth muscle cells.

Authors:  Bernadette Chen; Andrea E Calvert; Xiaomei Meng; Leif D Nelin
Journal:  Am J Respir Cell Mol Biol       Date:  2012-03-23       Impact factor: 6.914

Review 6.  Functional cross-talk between the cyclic AMP and Jak/STAT signaling pathways in vascular smooth muscle cells.

Authors:  S Meloche; S Pelletier; M J Servant
Journal:  Mol Cell Biochem       Date:  2000-09       Impact factor: 3.396

Review 7.  Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development.

Authors:  William G Robichaux; Xiaodong Cheng
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

8.  Molecular cloning and sequence analysis of the promoter region of mouse cyclin D1 gene: implication in phorbol ester-induced tumour promotion.

Authors:  I Eto
Journal:  Cell Prolif       Date:  2000-06       Impact factor: 6.831

9.  Cyclic AMP blocks cell growth through Raf-1-dependent and Raf-1-independent mechanisms.

Authors:  Nicolas Dumaz; Yvonne Light; Richard Marais
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

10.  Identity of adenylyl cyclase isoform determines the rate of cell cycle progression in NIH 3T3 cells.

Authors:  M J Smit; D Verzijl; R Iyengar
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.